Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05316_nanopub.RA1qRcNcizeHpivmle0dK7_p12XKqZDTAXCHt5AE8fB7o#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB05316 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05316 label "ACP-103 [drugbank:DB05316]" assertion.
- drugbank:DB05316 seeAlso DB05316 assertion.
- drugbank:DB05316 identifier "drugbank:DB05316" assertion.
- drugbank:DB05316 description "ACP-103 is a potent and selective 5-HT2A inverse agonist, as a co-therapy for schizophrenia. ACP-103 is a novel therapy for schizophrenia to be used in combination with currently available antipsychotic drugs including haloperidol, Zyprexa, Risperdal and Seroquel." assertion.
- drugbank:DB05316 title "ACP-103" assertion.
- drugbank:DB05316 bio2rdf_vocabulary:identifier "DB05316" assertion.
- drugbank:DB05316 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05316 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05316" assertion.
- drugbank:DB05316 bio2rdf_vocabulary:x-identifiers.org DB05316 assertion.
- drugbank:DB05316 drugbank_vocabulary:drugbank-id "DB05316" assertion.
- drugbank:DB05316 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05316 drugbank_vocabulary:x-chemspider chemspider:9847221 assertion.
- drugbank:DB05316 drugbank_vocabulary:x-pubchemcompound pubchem.compound:11672491 assertion.